Search
for
Sort by
Research 841–870 of 1000+
- Cyclosporine-induced alopecia:a case report, FDA adverse event reporting system analysis and literature assessment
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- E-Poster
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Drug Armamentarium for alopecia areata
- Systemic Antifungals
- Acne Vulgaris
- Acne vulgaris: recognition and management
- Current and Future Medical Treatment of Androgenetic Alopecia
- Actinic keratosis: a clinical and epidemiological revision
- Non-viral delivery of the CRISPR/Cas system: DNA<i>versus</i>RNA<i>versus</i>RNP
- Regenerative Medicine-Based Treatment for Vitiligo: An Overview
- Alopecia areata – Current understanding and management
- Clinical and histopathological characteristics in patients with scarring folliculitis type of acne inversa
- Fertility counseling and preservation: considerations for the pediatric endocrinologist
- Non-classical congenital adrenal hyperplasia: current insights into clinical implications, diagnosis and treatment
- Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
- Cancer prevalence after exposure to Wnt-activating drugs: a systematic review
- Case Report: Tuberculosis lymphadenitis with systemic lupus erythematosus in a young woman: a case report
- Case Report: Tuberculosis lymphadenitis with systemic lupus erythematosus in a young woman: a case report
- Referee report. For: Case Report: Tuberculosis lymphadenitis with systemic lupus erythematosus in a young woman: a case report [version 1; peer review: 2 approved with reservations]
- Adipose tissue protects against skin photodamage through CD151- and AdipoQ- EVs
- Safety and Efficacy of Nutrition-Based Interventions for Hair
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Treatment options for polycystic ovary syndrome
- 2014 Female Athlete Triad Coalition Consensus Statement on Treatment and Return to Play of the Female Athlete Triad: 1st International Conference held in San Francisco, California, May 2012 and 2nd International Conference held in Indianapolis, Indiana, May 2013
- Polycystic ovary syndrome
- Vaccines, adjuvants and autoimmunity
- The Rotterdam Study: 2010 objectives and design update